Brief: Shenzhen Neptunus Interlong Bio-technique says unit entered into a distribution agreement
10/12/2015 09:27
Dec 10 (Reuters) - Shenzhen Neptunus Interlong Bio-technique Co Ltd 8329.HK : * Continuing connected transaction in relation to a distribution agreement 8329.HK * Neptunus changjian entered into the distribution agreement with neptunus pharmaceutical * Pursuant to deal Neptunus Changjian will purchase pharmaceutical products manufactured by neptunus pharmaceutical * Says term of the distribution agreement is from 1 January 2016 to 31 December 2018 * Source text for Eikon ID:nHKS6sB2Fk ((For more news, please click here 8329.HK )) ((Bengaluru Newsroom; +91 80 6749 1130))
Recent news on Shenzhen Neptunus Interlong Bio-technique
See all newsBrief: Shenzhen Neptunus Interlong Bio-Technique's Unit Enters Into JV Agreement With Huikang Bio-Technology
China's Neptunus Interlong H1 revenue falls
Brief: Shenzhen Neptunus Interlong Bio-Technique Expects Net Profit Attributable To Owners Of RMB 7 Million For 2026 Interim Period
Brief: Shenzhen Neptunus Interlong Bio-Technique Posts FY Loss & Total Comprehensive Expenses Attributable RMB40.7 Million
Brief: Shenzhen Neptunus Interlong Bio-Technique Sees FY Net Loss Attributable Of RMB40 Million